CompletedNot applicableNCT00746759

Airway Epithelium Gene Expression: AEGIS IDE

The purpose of the research study is to develop a new, more sensitive, and less invasive test for diagnosing lung cancer at an earlier stage, when it can more easily be cured. The investigators hypothesize that certain genes are expressed differently in current and former smokers who have lung cancer, and this difference in gene expression may be a biomarker for lung cancer.

Checked against the public recordLast updated Jun 4, 2015 · Source: ClinicalTrials.gov

StatusCompleted
PhaseNot applicable
U.S. locations21
SponsorAllegro Diagnostics, Corp.
01
Study overview

What this study is about

Purpose
Not specified
Study type
Observational
Phase
Not applicable
Sponsor
Allegro Diagnostics, Corp.
Interventions being studied
Device: Biomarker (not used as an intervention)
02
Explore related studies

How this study is categorized

These labels come from structured fields and exact terms in the public record.

03
Public criteria

Who may be able to participate

Inclusion Criteria: * Patients being evaluated for the diagnosis of possible lung cancer or "rule out lung cancer" and undergoing clinically indicated bronchoscopy * All patients are required to be at least 21 years of age and be able to understand and sign the informed consent form * Patient must be a current or former cigarette smoker Exclusion Criteria: * A pulmonary physician does not recommend that bronchoscopy be performed * Inability to understand the written consent form and comply with requirements of the study * History of prior primary lung cancer * Immediately prior to bronchoscopy, the patient has been on a mechanical ventilator for \>24 consecutive hours.

Important: This is the sponsor’s public criteria, not a determination of eligibility. The study team must review your individual situation.

04
Study sites

U.S. locations

  • University of AlabamaBirmingham, Alabama
  • Pulmonary Associates of ArizonaPhoenix, Arizona
  • University of California- DavisSacramento, California
  • National Jewish HealthDenver, Colorado
  • Yale UniveristyNew Haven, Connecticut
  • North Florida/South Georgia VAGainesville, Florida
  • Indiana UniversityIndianapolis, Indiana
  • LSUNew Orleans, Louisiana
  • St. Elizabeth's Medical CenterBoston, Massachusetts
  • University of MissouriColumbia, Missouri
  • Pulmonary and Allergy Associates of New JerseySummit, New Jersey
  • Jamaica Hospital Medical CenterJamaica, New York

Source and freshness
Processed from ClinicalTrials.gov. Last public update: Jun 4, 2015. Always confirm current availability with the study team.

View original record ↗